Daiichi Sankyo Healthcare Direct Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President: Hiroshi Yaegashi) will release 'Brightage White Premium' on June 11, 2026 (Thursday). 'Brightage White' is a Class 3 pharmaceutical born from 17 years of research into spot and freckle causes by Daiichi Sankyo Healthcare. It will be sold primarily online through the company's own EC site, Amazon, and official Rakuten shops. 'Brightage White' [Class 3 pharmaceutical], released in 2020, has grown into a popular product driving the brand's overall growth, with an increasing number of users regardless of age or gender. As the number of users has grown, we have received many requests for 'more serious spot care' and 'products with higher satisfaction.' Therefore, we have increased the number of active ingredients to eight and challenged ourselves to increase the number of active ingredients at the maximum approved concentration. We are releasing 'Brightage White Premium' [Class 3 pharmaceutical], which has the highest concentration of active ingredients in Brightage White history.
FACT BOX
- Source: PR TIMES
- Category: product_launch